Graudins Andis, Meek Robert, Parkinson Jacqueline, Egerton-Warburton Diana, Meyer Alastair
Monash Health Emergency Medicine Research Unit, Dandenong Hospital, Melbourne, Victoria, Australia.
Monash Emergency, Dandenong Hospital, Melbourne, Victoria, Australia.
Emerg Med Australas. 2016 Dec;28(6):666-672. doi: 10.1111/1742-6723.12672. Epub 2016 Sep 7.
Compare pain relief from non-opioid, codeine and oxycodone analgesic regimens in adults with moderate pain from limb injury.
Double-blind, randomised, controlled, non-inferiority trial. Three regimens of six tablets, each included 2 × 500 mg paracetamol and 2 × 200 mg ibuprofen with 2 × 100 mg thiamine (non-opioid), 2 × 30 mg codeine (codeine) or 2 × 5 mg oxycodone tablets (oxycodone).
difference in mean visual analogue scale (VAS) change between groups at 30 min, with a limit of inferiority of 13. Secondary outcomes included mean change in VAS rating from baseline to 30 min for each group, patient satisfaction, need for additional analgesia and adverse events. Pain ratings taken at 60 and 90 min for patients still in ED are described.
Of 182 patients randomised, non-opioid, codeine and oxycodone numbers were 61, 62 and 59. Differences (95% CI) between groups at 30 min were as follows: non-opioid versus codeine -2.6 (-8.8 to 3.6); non-opioid versus oxycodone -2.7 (-9.3 to 3.9); codeine versus oxycodone 0.1 (-6.6 to 6.4). Mean VAS reductions for non-opioid, codeine and oxycodone were -13.5, -16.1 and -16.2 mm, respectively. Satisfaction with analgesia was reported by 77.6% (64.7-87.5), 81.0% (67.2-89.0) and 73.6% (59.7-84.7) and adverse events by 3.3% (0.4-11.3), 1.6% (0.4-8.7) and 16.9% (8.4-29.0), respectively. Mean VAS reductions at 60 and 90 min were as follows: -23.2 and -18.7 mm for non-opioid; -30.7 and -33.3 mm for codeine; and -26.1 and -31.7 mm for oxycodone.
At 30 min, analgesic effects of non-opioid, codeine and oxycodone groups were non-inferior.
比较非阿片类、可待因和羟考酮镇痛方案对因肢体损伤导致中度疼痛的成年人的止痛效果。
双盲、随机、对照、非劣效性试验。三种方案各含六片药,每种方案均包含2×500毫克对乙酰氨基酚、2×200毫克布洛芬和2×100毫克硫胺素(非阿片类)、2×30毫克可待因(可待因)或2×5毫克羟考酮片(羟考酮)。
30分钟时各组之间平均视觉模拟量表(VAS)变化的差异,非劣效性界限为13。次要结局包括每组从基线到30分钟VAS评分的平均变化、患者满意度、额外镇痛需求及不良事件。描述了仍在急诊科的患者在60分钟和90分钟时的疼痛评分。
182例随机分组患者中,非阿片类、可待因和羟考酮组分别有61例、62例和59例。30分钟时各组之间的差异(95%CI)如下:非阿片类与可待因比较为-2.6(-8.8至3.6);非阿片类与羟考酮比较为-2.7(-9.3至3.9);可待因与羟考酮比较为0.1(-6.6至6.4)。非阿片类、可待因和羟考酮组的平均VAS降低值分别为-13.5、-16.1和-16.2毫米。镇痛满意度报告分别为77.6%(64.7-87.5)、81.0%(67.2-89.0)和73.6%(59.7-84.7),不良事件发生率分别为3.3%(0.4-11.3)、1.6%(0.4-8.7)和16.9%(8.4-29.0)。60分钟和90分钟时的平均VAS降低值如下:非阿片类为-23.2和-18.7毫米;可待因为-30.7和-33.3毫米;羟考酮为-26.1和-31.7毫米。
30分钟时,非阿片类、可待因和羟考酮组的镇痛效果无差异。